Previous Page  2 / 14 Next Page
Information
Show Menu
Previous Page 2 / 14 Next Page
Page Background

Page 30

Journal of Skin

Notes:

September 18-20, 2017 SAN ANTONIO, TX, USA

World Dermatological Congress

Dermatology Congress 2017

http://dermatology.cmesociety.com

The in-hospital financial burdenof hidradenitis suppurativa inpatientswith inflammatory

bowel disease

Alvaro J Ramos-Rodriguez, Ali Khan, Lauren Bonomo, Dmitriy Timerman, Yiming Luo andAlejandro Lemor

Icahn School of Medicine at Mount Sinai West, USA

Background:

Hidradenitis suppurativa (HS), formerly known as acne in versa, is a chronic inflammatory

and debilitating disease that significantly affects the patient’s quality of life. There is a high prevalence of HS

in patients with inflammatory bowel disease (IBD), which further compromises quality of life in this patient

population. In this study, we sought to explore the in-hospital financial burden of HS in patients with IBD given

the lack of published literature on this topic.

Methods:

This was a retrospective cohort study using the National Inpatient Sample (NIS) for the years 2008

through 2014. All patients with ICD-9 CM codes for any diagnosis of Inflammatory Bowel Disease (IBD) from

2008 to 2014 across the US were included. There were no exclusion criteria. Patients with IBD were classified

as having hidradenitis suppurativa (HS) and not having HS using ICD-9 CM code 705.83. The primary outcome

was the financial burden of HS on patients with IBD. The financial burden was measured by resource utilization

which included median hospital length of stay (LOS), imaging and bedside procedures (i.e., abdominal CT-

scan, incision and drainage) and mean hospitalization costs. Data of patient’s insurance and disposition was also

collected.

Results:

A total of 3,079,332 admissions with inflammatory bowel disease (IBD) were included in the study,

of which 4,369 had a diagnosis of hidradenitis suppurativa (HS). Patients with HS-IBD displayed increased

additional hospital length of stay when compared to IBD patients without HS (4 days vs 5 days, p<0.001). Patients

with IBD-HS incurred significantly higher additional total hospital costs when compared to IBD patients without

HS (Mean additional costs: $ 1,035, p=0.013). There was no difference in additional imaging (i.e. abdominal

CT-scan) between the two groups. Patients with IBD-HS had significantly more incision and drainage procedures

than those without HS (0.7% vs 10.8%, p<0.001). Additionally, more patients with IBD-HS had Medicare and

Medicaid insurance compared to those without HS (61% vs 47.7%, p<0.001).

Conclusion:

We conclude that there is a significant increase in-hospital financial burden in IBD patients with

hidradenitis suppurativa compared to those with IBD only. Patients with IBD-HS had increased resource utilization

including hospital length of stay, mean total hospitalization costs and bedside procedures. more patients with

IBD-HS had lower household income and were insured by Medicare and Medicaid.

Biography

Alvaro J Ramos-Rodriguez is currently a Medical Resident Physician at the Icahn School of Medicine at Mount Sinai West. He is the Author of the recently

published textbook

Dermatology for the USMLE

. He has dedicated a major part of his medical career to teaching and helping students prepare for the USMLE,

including teaching review courses. His interest is in dermatology including DRESS syndrome, toxic erythema of chemotherapy, atopic dermatitis, hidradenitis

suppurativa, psoriasis and infectious skin disorders.

Alvaro.Ramos-Rodriguez@mountsinai.org